Biovista to host Drug Repositioning Workshop at 2nd World PGX Summit

March 20, 2012Events

CHARLOTTESVILLE, Virginia, March 20, 2012 — Biovista announced today that it will be organizing a workshop on drug repositioning at the upcoming World Pharmacogenomics Summit being held April 24-26 in Boston. The Workshop entitled “Understand How to Use PGx in Drug Repositioning, Adverse Event Prediction, Patient Subpopulation Stratification and Personalized Medicine” will help strategic level … Read More

Pharmaceutical Engineering interview with Dr. Aris Persidis

March 6, 2012Biovista Articles

Industry Interview Series: Dr. Aris Persidis, President and Co-founder, Biovista, Inc. Online article in  Pharmaceutical Engineering Magazine. With patent expirations looming for many major pharmaceutical companies, drug repositioning has become a matter of intense interest during the past few years. Biovista’s President and Co-founder discusses the basics of drug repositioning and the potential impact it … Read More

Biovista Awarded Research Grant on Chronic Fatigue Syndrome From Solve ME/CFS Initiative

March 6, 2012Press Releases

CHARLOTTESVILLE, Virginia, March 6, 2012 /PRNewswire/ — Biovista announced today that it has been awarded a prestigious research grant by Solve ME/CFS Initiative to identify non-obvious mechanisms of the disease and potential drug repositioning candidates that will advance objective diagnosis and effective treatment of chronic fatigue syndrome (CFS). As part of its work, Biovista will share … Read More